Arul Veerappan

Dr. Arul Veerappan

New York University School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
AVArul Veerappan
Arul Veerappan
SMShigeru Miyazaki
Shigeru Miyazaki
RDRenganathan Dhananjayan
Renganathan Dhananjayan

1 April 2013 in DNA and Cell Biology
Verified
Journal Article
Closed access
AVArul Veerappan
Arul Veerappan
NONathan J. O'COnnor
Nathan J. O'COnnor
JBJacqueline Brazin
Jacqueline Brazin
ARAlicia C. Reid
Alicia C. Reid
AJAlbert Jung
Albert Jung
RSRandi B. Silver
Randi B. Silver
Pulmonary fibrosis is characterized by an inflammatory response that includes macrophages, neutrophils, lymphocytes, and mast cells. The purpose of this study was to evaluate whether mast cells play a role in initiating pulmonary fibrosis. Pulmonary fibrosis was induced with bleomycin in mast-cell-deficient WBB6F1-W/Wv (MCD) mice and their congenic controls (WBB6F1-+/+). Mast cell deficiency protected against bleomycin-induced pulmonary fibrosis, but protection was reversed with the re-introduction of mast cells to the lungs of MCD mice. Two mast cell mediators were identified as fibrogenic: histamine and renin, via angiotensin (ANG II). Both human and rat lung fibroblasts express the histamine H1 and ANG II AT1 receptor subtypes and when activated, they promote proliferation, transforming growth factor β1 secretion, and collagen synthesis. Mast cells appear to be critical to pulmonary fibrosis. Therapeutic blockade of mast cell degranulation and/or histamine and ANG II receptors should attenuate pulmonary fibrosis.

22 May 2013 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
TWTilla S. Worgall
Tilla S. Worgall
AVArul Veerappan
Arul Veerappan
BSBiin Sung
Biin Sung
BKBenjamin I. Kim
Benjamin I. Kim
EWEvan Weiner
Evan Weiner
SWStefan Worgall
Stefan Worgall
Decreased activity of serine palmitoyl-CoA transferase is associated with asthma.

1 February 2007 in Phytomedicine
Verified
Journal Article
Closed access
AVArul Veerappan
Arul Veerappan
SMS. Miyazaki
S. Miyazaki
MKM. Kadarkaraisamy
M. Kadarkaraisamy
DRD. Ranganathan
D. Ranganathan

29 January 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
AVArul Veerappan
Arul Veerappan
ARAlicia C. Reid
Alicia C. Reid
RERacha Estephan
Racha Estephan
NONathan O'COnnor
Nathan O'COnnor
MTMaria Thadani-Mulero
Maria Thadani-Mulero
RSRandi B. Silver
Randi B. Silver
We previously reported that mast cells express renin, the rate-limiting enzyme in the renin–angiotensin cascade. We have now assessed whether mast cell renin release triggers angiotensin formation in the airway. In isolated rat bronchial rings, mast cell degranulation released enzyme with angiotensin I-forming activity blocked by the selective renin inhibitor BILA2157. Local generation of angiotensin (ANG II) from mast cell renin elicited bronchial smooth muscle contraction mediated by ANG II type 1 receptors (AT1R). In a guinea pig model of immediate type hypersensitivity, anaphylactic mast cell degranulation in bronchial rings resulted in ANG II-mediated constriction. As in rat bronchial rings, bronchoconstriction (BC) was inhibited by a renin inhibitor, an AT1R blocker, and a mast cell stabilizer. Anaphylactic release of renin, histamine, and β-hexosaminidase from mast cells was confirmed in the effluent from isolated, perfused guinea pig lung. To relate the significance of this finding to humans, mast cells were isolated from macroscopically normal human lung waste tissue specimens. Sequence analysis of human lung mast cell RNA showed 100% homology between human lung mast cell renin and kidney renin between exons 1 and 10. Furthermore, the renin protein expressed in lung mast cells was enzymatically active. Our results demonstrate the existence of an airway renin–angiotensin system triggered by release of mast-cell renin. The data show that locally produced ANG II is a critical factor governing BC, opening the possibility for novel therapeutic targets in the management of airway disease.

30 January 2019 in Toxics
Verified
Journal Article
Open access
PDF file
ECemily clementi
emily clementi
ATAngela Talusan
Angela Talusan
SVSandhya Vaidyanathan
Sandhya Vaidyanathan
AVArul Veerappan
Arul Veerappan
MMMena Mikhail
Mena Mikhail
ANAnna Nolan
Anna Nolan
Particulate matter (PM) exposure and metabolic syndrome (MetSyn) are both significant global health burdens. PM exposure has been implicated in the pathogenesis of MetSyn and cardiopulmonary diseases. Individuals with pre-existing MetSyn may be more susceptible to the detrimental effects of PM exposure. Our aim was to provide a narrative review of MetSyn/PM-induced systemic inflammation in cardiopulmonary disease, with a focus on prior studies of the World Trade Center (WTC)-exposed Fire Department of New York (FDNY). We included studies (1) published within the last 16-years; (2) described the epidemiology of MetSyn, obstructive airway disease (OAD), and vascular disease in PM-exposed individuals; (3) detailed the known mechanisms of PM-induced inflammation, MetSyn and cardiopulmonary disease; and (4) focused on the effects of PM exposure in WTC-exposed FDNY firefighters. Several investigations support that inhalation of PM elicits pulmonary and systemic inflammation resulting in MetSyn and cardiopulmonary disease. Furthermore, individuals with these preexisting conditions are more sensitive to PM exposure-related inflammation, which can exacerbate their conditions and increase their risk for hospitalization and chronic disease. Mechanistic research is required to elucidate biologically plausible therapeutic targets of MetSyn- and PM-induced cardiopulmonary disease.